CRP/albumin ratio is used as a prognostic mediator for several cancers such as hepatocellular lung cancer, newly diagnosed pancreatic cancer, renal cancer or ovarian cancer (44). This evidence concerns the gene ALB and familial pancreatic carcinoma.